VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AAME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AAMEAtlantic American Corporation
$1.72$35M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAAMEQuarterly Financials

Atlantic American Corporation (AAME) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Atlantic American Corporation (AAME) quarterly income statement — complete revenue, gross profit & net income history

AAME Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Revenue53.76M55.29M50.13M49.04M44.52M47.67M47M46.74M44.59M49.19M46.27M45.23M46.34M44.67M51.61M49.73M49.29M51.46M49.08M59.93M
Revenue Growth %20.76%15.99%6.66%4.92%-0.16%-3.09%1.57%3.35%-3.78%10.12%-10.35%-9.05%-5.98%-13.19%5.16%-17.02%6.53%3.46%24.52%14.62%
Medical Costs & Claims35.12M46.52M43.59M43.63M42.25M43.39M31.93M45.15M37.88M42.21M43.38M39.72M43.47M42.97M44.01M42.5M46.97M43.88M45.84M42.13M
Medical Cost Ratio %65.33%84.13%86.97%88.96%94.9%91.03%67.93%96.59%84.95%85.82%93.75%87.82%93.81%96.19%85.27%85.46%95.3%85.28%93.4%70.29%
Gross Profit18.64M8.77M6.53M5.41M2.27M4.28M15.07M1.59M6.71M6.97M2.89M5.51M2.87M1.7M7.6M7.23M2.32M7.58M3.24M17.8M
Gross Margin %34.67%15.87%13.03%11.04%5.1%8.97%32.07%3.41%15.05%14.18%6.25%12.18%6.19%3.81%14.73%14.54%4.7%14.72%6.6%29.71%
Gross Profit Growth %721.42%105.12%-56.66%239.65%-66.18%-38.68%421.34%-71.06%133.76%310.05%-61.98%-23.84%23.81%-77.54%134.73%-59.38%-60.36%-35.84%147.64%209.17%
Operating Expenses17.87M4.56M5.5M4.87M4.72M5.13M16.72M4.7M4.57M4.76M4.71M4.14M3.82M3.82M3.81M3.84M3.61M3.82M3.79M2.79M
OpEx / Revenue %33.24%8.24%10.97%9.93%10.61%10.75%35.58%10.05%10.25%9.67%10.18%9.16%8.24%8.54%7.38%7.73%7.33%7.43%7.71%4.65%
Depreciation & Amortization97K103K77K69K59K125K113K131K164K169K188K207K218K225K240K250K243K246K264K208K
Combined Ratio %98.57%92.37%97.94%98.89%105.51%101.78%103.51%106.64%95.21%95.49%103.93%96.98%102.05%104.73%92.64%93.19%102.62%92.7%101.11%74.94%
Operating Income769K4.22M1.03M545K-2.45M-849K-1.65M-3.1M2.14M2.22M-1.82M1.36M-949K-2.12M3.8M3.39M-1.29M3.75M-547K15.02M
Operating Margin %1.43%7.63%2.06%1.11%-5.51%-1.78%-3.51%-6.64%4.79%4.51%-3.93%3.02%-2.05%-4.73%7.36%6.81%-2.62%7.3%-1.11%25.06%
Operating Income Growth %131.34%596.58%162.69%117.57%-214.78%-138.29%9.19%-327.42%325.29%204.82%-147.89%-59.74%26.6%-156.34%793.97%-77.44%-153.14%-54.67%94.65%815.05%
EBITDA866K4.32M1.11M614K-2.4M-724K-1.54M-2.97M2.3M2.39M-1.63M1.57M-731K-1.89M4.04M3.64M-1.05M4M-283K15.22M
EBITDA Margin %1.61%7.81%2.22%1.25%-5.38%-1.52%-3.27%-6.36%5.16%4.85%-3.52%3.47%-1.58%-4.23%7.82%7.32%-2.13%7.77%-0.58%25.4%
Interest Expense779K773K774K828K869K867K855K862K850K807K750K661K523K414K354K347K347K347K346K357K
Non-Operating Income-779K-773K-774K-828K-869K-867K0-862K-850K-807K-750K-661K-523K-414K-354K-347K-347K-347K-346K-357K
Pretax Income769K4.22M1.03M545K-2.45M-849K-2.51M-3.1M2.14M2.22M-1.82M1.36M-949K-2.12M3.8M3.39M-1.29M3.75M-547K15.02M
Pretax Margin %1.43%7.63%2.06%1.11%-5.51%-1.78%-5.33%-6.64%4.79%4.51%-3.93%3.02%-2.05%-4.73%7.36%6.81%-2.62%7.3%-1.11%25.06%
Income Tax192K900K233K133K-456K-165K-508K-874K379K473K-372K318K-265K-436K954K723K-378K792K-116K3.17M
Effective Tax Rate %24.97%21.35%22.51%24.4%18.58%19.43%20.27%28.18%17.73%21.34%20.46%23.31%27.92%20.61%25.13%21.34%29.23%21.1%21.21%21.1%
Net Income577K3.32M802K412K-2M-684K-2M-2.23M1.76M1.74M-1.45M1.05M-684K-1.68M2.84M2.67M-915K2.96M-431K11.85M
Net Margin %1.07%6%1.6%0.84%-4.49%-1.43%-4.25%-4.77%3.94%3.55%-3.13%2.31%-1.48%-3.76%5.51%5.36%-1.86%5.76%-0.88%19.77%
Net Income Growth %128.88%584.8%140.14%118.49%-213.59%-139.22%-38.17%-313%357.16%203.87%-150.88%-60.75%25.25%-156.68%759.4%-77.51%-148.77%-54.65%94.67%832.91%
EPS (Diluted)0.030.150.030.02-0.10-0.04-0.10-0.110.080.08-0.070.05-0.03-0.080.130.12-0.040.14-0.020.54
EPS Growth %127.07%490.63%134.5%113.91%-228.48%-150.86%-41.04%-337.07%327.46%191.74%-154.54%-61.33%25.39%-158.79%716.11%-77.78%-149.89%-53.33%94.73%800%
EPS (Basic)0.030.160.030.02-0.10-0.04-0.10-0.110.080.08-0.070.05-0.03-0.080.140.13-0.050.14-0.020.58
Diluted Shares Outstanding21.77M21.77M20.4M20.4M20.4M20.4M20.4M20.4M21.78M21.78M20.41M20.39M20.39M20.4M21.76M22.21M20.4M21.79M20.41M21.94M